Robotic-Assisted Cancer Surgery

Robotic-assisted cancer surgery at SilverOak Health harnesses the da Vinci Surgical System's precision, three-dimensional visualisation, and wristed instrument dexterity to perform oncological resections with the dual goals of complete tumour clearance and maximal preservation of surrounding healthy tissue and function. Our robotic oncological surgeons are among the most experienced in the country, performing high-volume procedures with outcomes consistently at or above national benchmarks.

Robotic cancer surgery is offered for prostate cancer (radical prostatectomy), bladder cancer (cystectomy with urinary diversion), kidney cancer (partial and radical nephrectomy), colorectal cancer (right and left hemicolectomy, anterior resection, abdominoperineal resection), endometrial and cervical cancer (radical hysterectomy with lymph node dissection), and thyroid cancer (remote-access thyroidectomy). Each tumour type has specialised dissection planes, lymphadenectomy templates, and reconstruction requirements that our subspecialty-trained surgical oncologists have mastered through dedicated training and high caseloads.

The advantages of the robotic approach in cancer surgery are particularly meaningful: precise dissection around neurovascular bundles in prostatectomy preserves continence and erectile function to a degree not consistently achievable with open surgery; articulated instruments and magnified vision in pelvic surgery reduce blood loss and lymphatic injury; and small incisions minimise wound complications in patients whose immune systems may be compromised by concurrent chemotherapy or nutritional depletion. Our cancer surgery outcomes are discussed at weekly multidisciplinary tumour board meetings attended by oncologists, radiologists, and pathologists, ensuring every patient's care plan reflects the best available evidence.